Jeffrey S. Boggs - 06 Jan 2023 Form 3 Insider Report for EchoStar CORP (SATS)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
17 Jan 2023, 15:15:46 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jeffrey S. Boggs, by Dean Manson, his Attorney-in-Fact

Key filing fact

Jeffrey S. Boggs filed Form 3 for EchoStar CORP (SATS) on 17 Jan 2023.

Key facts

  • This page summarizes Jeffrey S. Boggs's Form 3 filing for EchoStar CORP (SATS).
  • 0 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 17 Jan 2023, 15:15.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SATS holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,753
Date
06 Jan 2023
Ownership
Direct
SATS holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,182
Date
06 Jan 2023
Ownership
By 401(k) Plan

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SATS holding Derivative

Employee stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
06 Jan 2023
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
6,721
Exercise price
$24.49
Footnotes
F1
SATS holding Derivative

Employee stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
06 Jan 2023
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
3,279
Exercise price
$24.49
Footnotes
F2
SATS holding Derivative

Employee stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
06 Jan 2023
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
10,000
Exercise price
$38.89
Footnotes
F3
SATS holding Derivative

Employee stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
06 Jan 2023
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
3,452
Exercise price
$40.72
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The option vested as to 907 shares on July 1, 2022, vests as to 907 shares on each of July 1, 2023 and July 1, 2024, and vests as to 2,000 shares on each of July 1, 2025 and July 1, 2026.

Footnote F2

The option vested as to 1,093 shares on July 1, 2022 and the remainder vests in two equal annual installments beginning on July 1, 2023.

Footnote F3

The option vested as to 2,000 shares on each of October 1, 2020, October 1, 2021 and October 1, 2022, and the remainder vests in two equal annual installments beginning on October 1, 2023.

Footnote F4

The option vested in five annual installments beginning on October 1, 2015 and became fully vested on October 1, 2019.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .